阿尼芬净是一种半合成的环状脂肽，属于echinocandin类，1995年被报道，由礼来公司商业开发。Anidulafungin抑制β-（1,3）-D-葡聚糖的合成，β-（1,3）-D-葡聚糖是易感真菌细胞壁的重要组成部分，在文献中被引用超过400次。 Anidulafungin is a semi-synthetic cyclic lipopeptide belonging to the echinocandin class that was reported in 1995 and commercially developed by Eli Lilly. Anidulafungin inhibits the synthesis of β-(1,3)-D-glucan, an essential component of the cell wall of susceptible fungi and is extensively referenced in the literature with over 400 citations.